U.S. regulators on Monday approved Biogen Inc’s aducanumab as the first treatment to attack a likely cause of Alzheimer’s disease despite controversy over whether the clinical evidence proves the drug works. Aducanumab aims to remove sticky deposits of a protein called amyloid-beta from the brains of patients in earlier stages …
Read More »At least 43 children’s deaths in India ‘linked to lychee fruit toxin’
At least 43 children have died in less than two weeks in the Indian state of Bihar from a brain disease that scientists believe could be linked to consumption of lychee fruit. Health officials said the children died at two hospitals in Muzaffarpur, a region of the state that is …
Read More »